FTC Chairwoman Edith Ramirez announces the settlement with Herbalife. CNBC's David Faber provides perspective.
Carl Icahn, Herbalife's largest shareholder releases a statement after the FTC announces it reached a $200 million settlement with Herbalife.
The FTC and Herbalife have reached an agreement, reports CNBC's Scott Wapner.
Walgreens' Pessina estimates that the combined company will have to sell roughly 500 stores in order to gain regulatory approval from the FTC.
Shares of Walgreens and Rite Aid skyrocketed around 4 percent amid reports that the FTC is likely to approve Walgreens' acquisition of Rite Aid.
The court did the right thing by shredding the Staples-Office Depot deal, a former FTC commissioner said Wednesday.
CNBC's Dominic Chu looks at shares of Alphabet after a report from Politico saying the FTC could take a second look into Google's search dominance.
Frank Aquila, Sullivan & Cromwell Partner and Mergers & Acquisition Attorney, speaks about the climate for M&A and why so many deals have been blocked recently.
Former FTC Commissioner Julie Brill weighs in on the Federal Trade Commission stopping a deal between Office Depot and Staples for antitrust reasons as well as the state of M&A activity in the U.S.
Staples and Office Depot became the latest companies to abandon plans for a merger after facing scrutiny on antitrust grounds.
U.S. authorities have asked mobile phone carriers and manufacturers including Apple and Samsung, to explain how they release security updates.
Shares in Herbalife jumped more than 13 percent in after-hours trading.
CNBC's David Faber looks at the Staples/Office Depot antitrust case, the Williams lawsuit against ETE and ETP CEO Kelcy Warren, and whether the Halliburton/Baker Hughes deal will go to court.
Julie Brill, FTC Commissioner, and Steve Odland, CNBC Contributor and former Office Depot CEO, discuss the FTC's opposition of the proposed merger between Staples and Office Depot on antitrust allegations.
The FTC charges that Lord & Taylor deceived consumers by paying for an article in Nylon magazine without disclosing its role.
Herbalife soundly beat Wall Street expectations Thursday, reporting earnings per share of $1.19.
It turns out that social media patterns aren't great at predicting a person's creditworthiness, The Wall Street Journal reports.
Major health insurers are still a long way from gaining federal approval for their mergers, but they're optimistic their deals will close by year-end.
Federal officials announced a broad range of actions against dietary supplement companies Tuesday, with CNBC's Eamon Javers; and Dominic Chu provides insight to the stock moves.
The FTC sues diet pill maker Roca Labs for trying to silence unhappy customers and making "outrageously deceptive claims" for its products.